Avapritinib, a Potent and Selective Inhibitor of KIT D816V, Improves Symptoms of Advanced Systemic Mastocytosis (AdvSM): Analyses of Patient Reported Outcomes (PROs) from the Phase 1 (EXPLORER) Study Using the (AdvSM) Symptom Assessment Form (AdvSM-SAF), a New PRO Questionnaire for (AdvSM) Gotlib, J. R., Radia, D., DeAngelo, D. J., Bose, P., Drummond, M. W., Hexner, E. O., Robinson, W. A., Conlan, M. G., Oren, R. G., Shi, H., Deininger, M. W. AMER SOC HEMATOLOGY. 2018

View details for DOI 10.1182/blood-2018-99-112017

View details for Web of Science ID 000454837601060